News

FDA approves the world's only twice-a-year shot to prevent HIV
WASHINGTON – The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
MBTA to borrow $939 million as deficit looms
The MBTA plans to sell about $939 million in municipal bonds, according to preliminary bond documents. It is the latest US ...
Boston Herald3d
FDA approves the world’s only twice-a-year shot to prevent HIV
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ... Purdue Pharma’s $7B opioid settlement could advance after ...
Gilead Sciences: Strong Buy On Pipeline Momentum And Cost Discipline
Gilead Sciences shows strong Q1 execution, pipeline momentum, and margin upside, led by HIV and PrEP launches. See why GILD ...
STAT2d
Gilead’s CEO on the approval of a powerful new drug to prevent HIV
Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.
STAT3d
Gilead won U.S. approval for HIV prevention shot, but when will low-income countries gain sufficient access?
Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income ...
WAVY-TV3d
FDA approves the world’s only twice-a-year shot to prevent HIV
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout ...